EGFR gene amplifications are present in more than half of glioblastoma [73,74], while EGFRvIII, a truncated receptor resulting from the deletion of exons 2 to 7, is the most common EGFR oncogenic mutation in glioblastoma [75]. The gene discussed is EGFR; the disease is glioblastoma.